In the current study, consistent with the results from our previous NAFLD study [11], we found that serum TSP-2 levels were correlated with markers of liver fibrosis and injury, which account for both accumulated and incoming HCC risk, respectively, leading to the high potential to predict HCC occurrence even after HCV eradication. The gene discussed is THBS2; the disease is hepatocellular carcinoma.